Improved Pharma is pleased to announce a collaboration with Dr. Patricia Andres from Keystone Pharma Consulting, LLC, thus further expanding its network of pharmaceutical consultants with expertise in different areas of drug development to support its growing demand.

Dr. Andres, President and founder of Keystone Pharma Consulting, LLC, brings over 20 years’ experience in Materials Science and Particle Technology in pharmaceutical development, during which she helped over a hundred pharmaceutical and biotech companies address development challenges, solve complex polymorphism and crystallization issues, identify suitable materials for development, and develop or troubleshoot associated isolation processes.

“Keystone Pharma Consulting’s goal is to help biotech companies bridge the gap between drug substance and drug product development, selecting and isolating a better API to solve common issues of poor bioavailability or drug product processability,” stated Dr. Andres. “I am very much looking forward to new opportunities to collaborate with the Improved Pharma team; we share a love for smart science and making a difference.”

Added Dr. Pamela Smith, COO of Improved Pharma, “We are thrilled to add Dr. Andres’ unique skillset to our team. We have an established history of success together. Along with Dr. Bogdanowich-Knipp and Dr. Brett Cowans, Dr. Andres was part of my leadership team when I ran SSCI. We look forward to working together again to help our clients develop life-saving medicines.”

To learn more about our services, please contact us through Improved Pharma or Keystone Pharma Consulting.